SCHEMBL722893

SCHEMBL722893

CC[C@H](c1cccc(N(C(C)C)C(C)C)c1)c1cc(CO)ccc1OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MAPT P10636 2/20 0.37
TP53 P04637 1/20 0.37
XBP1 P17861 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MRGPRX4 Q96LA9 2/20 0.36
TSHR P16473 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35
HPGD P15428 1/20 0.35
APP P05067 1/20 0.35
INPPL1 O15357 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
FFAR4 Q5NUL3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2634518 1.00 CHRM2 (0.43) CHRM2CHRM1SMN1; SMN2NPC1RAB9A
SCHEMBL7756337 1.00 CHRM2 (0.43) CHRM2CHRM1SMN1; SMN2NPC1RAB9A
SCHEMBL3960558 0.85 MRGPRX4 (0.48) SMN1; SMN2NPC1RAB9AMAPTTP53
SCHEMBL723430 0.85 MRGPRX4 (0.48) SMN1; SMN2NPC1RAB9AMAPTTP53
SCHEMBL19212480 0.85 CHRM2 (0.40) CHRM2CHRM1MAPTTSHR
SCHEMBL19212482 0.85 CHRM2 (0.40) CHRM2CHRM1MAPTTSHR
Hydrochloric Acid SCHEMBL1354482 0.85 MRGPRX4 (0.47) SMN1; SMN2NPC1RAB9AMAPTTP53
Hydrochloric Acid SCHEMBL723194 0.85 MRGPRX4 (0.47) SMN1; SMN2NPC1RAB9AMAPTTP53
SCHEMBL4659036 0.83 CHRM2 (0.51) CHRM2CHRM1SMN1; SMN2NPC1RAB9A
SCHEMBL4660409 0.83 CHRM2 (0.51) CHRM2CHRM1SMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012098560-A2 PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST MSN LABORATORIES LIMITED (IN) 2012-07-26 WO claimed
WO-2012025941-A2 PROCESSES FOR THE PREPARATION OF FESOTERODINE CADILA HEALTHCARE LIMITED (IN) 2012-03-01 WO claimed
WO-2009037569-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF FESOTERODINE ACTAVIS GROUP PTC EHF (IS) 2009-03-26 WO claimed
EP-2800735-A2 PROCESS FOR THE PREPARATION OF FESOTERODINE Alembic Pharmaceuticals Limited (IN) 2014-11-12 EP disclosed
EP-2780317-A2 THE NOVEL REFERENCE MARKERS FOR FESOTERODINE FUMARATE Alembic Pharmaceuticals Limited (IN) 2014-09-24 EP disclosed
WO-2013046194-A2 THE NOVEL REFERENCE MARKERS FOR FESOTERODINE FUMARATE ALEMBIC PHARMACEUTICALS LIMITED (IN) 2013-04-04 WO disclosed
WO-2013035084-A2 PROCESS FOR THE PREPARATION OF FESOTERODINE ALEMBIC PHARMACEUTICALS LIMITED (IN) 2013-03-14 WO disclosed
WO-2012098560-A2 PROCESS FOR THE PREPARATION OF MUSCARINIC RECEPTOR ANTAGONIST MSN LABORATORIES LIMITED (IN) 2012-07-26 WO disclosed
WO-2012025941-A2 PROCESSES FOR THE PREPARATION OF FESOTERODINE CADILA HEALTHCARE LIMITED (IN) 2012-03-01 WO disclosed
EP-2323967-A2 FESOTERODINE COMPRISING A REDUCED AMOUNT OF DEHYDROXYFESOTERODINE Actavis Group PTC EHF (IS) 2011-05-25 EP disclosed
WO-2010010464-A2 FESOTERODINE SUBSTANTIALLY FREE OF DEHYDROXY IMPURITY ACTAVIS GROUP PTC EHF (IS) 2010-01-28 WO disclosed
WO-2009037569-A2 AN IMPROVED PROCESS FOR THE PREPARATION OF FESOTERODINE ACTAVIS GROUP PTC EHF (IS) 2009-03-26 WO disclosed
EP-1940774-A1 NEW SYNTHESIS OF SUBSTITUTED HYDROXYMETHYL PHENOLS Schwarz Pharma Ltd. (IE) 2008-07-09 EP disclosed
WO-2007137799-A1 NEW SYNTHESIS OF SUBSTITUTED HYDROXYMETHYL PHENOLS SCHWARZ PHARMA LTD. (IE) 2007-12-06 WO disclosed
EP-1230209-A2 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SCHWARZ PHARMA AG (DE) 2002-08-14 EP disclosed
WO-2001035957-A1 STABLE SALTS OF NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES SANOL ARZNEI SCHWARZ GMBH (DE) 2001-05-25 WO disclosed